ArticleFrontiers in pharmacology2024

Screening and evaluation of metabolites binding PRAS40 from Erxian decoction used to treat spinal cord injury.

Li Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.